Effects of clopidogrel, prasugrel and ticagrelor on prevention of stent thrombosis in patients underwent percutaneous coronary intervention: A network meta‐analysis

BACKGROUND: Clopidogrel, prasugrel and ticagrelor, acting on platelet P2Y12 receptor, are commonly used for prevention of stent thrombosis (ST) among patients who underwent percutaneous coronary intervention (PCI). This study aimed to compare the effects of these drugs by a systematic review and net...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Cardiol
Main Authors: Chen, Wenwen, Zhang, Chen, Zhao, Jian, Xu, Xiuxiu, Dang, Heqin, Xiao, Qiang, Li, Yuanmin, Hou, Haifeng
Formato: Artigo
Idioma:Inglês
Publicado: Wiley Periodicals, Inc. 2021
Assuntos:
Clinical Investigations
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8027588/
https://ncbi.nlm.nih.gov/pubmed/33704801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.23536
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares